Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC.
Socinski MA, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kong S, Lee A, Coleman S, Zou W, McCleland M, Shankar G, Reck M. Socinski MA, et al. Among authors: kong s. J Thorac Oncol. 2021 Nov;16(11):1909-1924. doi: 10.1016/j.jtho.2021.07.009. Epub 2021 Jul 24. J Thorac Oncol. 2021. PMID: 34311108 Free article.
Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure.
Barbie DA, Spira A, Kelly K, Humeniuk R, Kawashima J, Kong S, Koczywas M. Barbie DA, et al. Among authors: kong s. Clin Lung Cancer. 2018 Nov;19(6):e853-e859. doi: 10.1016/j.cllc.2018.07.004. Epub 2018 Aug 4. Clin Lung Cancer. 2018. PMID: 30087028 Free PMC article. Clinical Trial.
A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer.
Padda SK, Reckamp KL, Koczywas M, Neal JW, Kawashima J, Kong S, Huang DB, Kowalski M, Wakelee HA. Padda SK, et al. Among authors: kong s. Cancer Chemother Pharmacol. 2022 Jan;89(1):105-115. doi: 10.1007/s00280-021-04369-0. Epub 2021 Nov 13. Cancer Chemother Pharmacol. 2022. PMID: 34773474 Free PMC article. Clinical Trial.
Percutaneous Coronary Intervention (PCI) in Patients of Rheumatoid Arthritis(RA): A Systematic Review and Meta-Analysis.
Piplani S, Kostojchin A, Kong S, Sharma A, Brown D, Jelic V, Chaturvedi S, Reddy V, Chang Pieri K, Akpan E, Simpson T, Xiao W, Sakellakis M, Sharma A, Jain P, Radulovic M. Piplani S, et al. Among authors: kong s. Indian Heart J. 2024 Dec 20:S0019-4832(24)00566-2. doi: 10.1016/j.ihj.2024.12.002. Online ahead of print. Indian Heart J. 2024. PMID: 39710047 Free article.
ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer.
Chun JW, Shon HW, Gong JE, Lee MR, Lee YS, Kim SJ, Kang S, Kim S, Lee KY, Woo SM, Cho IR, Paik WH, Lee WJ, Kong SY, Ryu JK, Kim YT, Lee SH, Kim YH. Chun JW, et al. Among authors: kong sy. Biochim Biophys Acta Mol Basis Dis. 2024 Dec 15;1871(3):167625. doi: 10.1016/j.bbadis.2024.167625. Online ahead of print. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 39689762 Free article.
2,800 results